Thomas Werner

Thomas Werner, Ph.D., has been a member of the Board since 2011 and has been serving as the Vice-Chairman of the Board since 2018. He is also Chairman of the Corporate Governance Committee and a member of the Compensation Committee.

Mr. Werner served as senior vice president & managing director of Glaxo SmithKline Germany from 2001 to 2008. From 1997 to 2000, he was managing director for Glaxo Wellcome Germany and director of the Central European Region. He also led Bristol-Myers Squibb Germany and Convatec Germany/Central Europe.

Mr. Werner is senior independent non-executive director of Vectura Group plc. He also serves as the chairman of the investment advisory committee of the Health for Life Capital Fund of Seventure Partners. From January 2017 to September 2019 he was chairman of the board of Fertin Pharma A/S.

Mr. Werner graduated with a doctorate in chemistry from the University of Göttingen, Germany.